{"disease":{"id":"healthy-cohort","name":"healthy cohort"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01938898","title":"The NICOLA Recruitment Trial (NICOLA-RT)","phase":"NA","overall_status":"COMPLETED","enrollment_count":13000,"lead_sponsor_name":"Queen's University, Belfast","has_results":false},{"nct_id":"NCT01978522","title":"The NICOLA Questionnaire Trial (NICOLA-QT)","phase":"NA","overall_status":"COMPLETED","enrollment_count":8500,"lead_sponsor_name":"Queen's University, Belfast","has_results":false},{"nct_id":"NCT06334705","title":"EGEA4 THE 30 YEAR FOLLOW UP OF THE EGEA STUDY","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT02092480","title":"The If I Were Jack Feasibility Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":630,"lead_sponsor_name":"Queen's University, Belfast","has_results":false},{"nct_id":"NCT03653936","title":"Neuro-ocular Baselines in a Sports Setting","phase":"","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Rebiscan, Inc.","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}